1254. Molecular Epidemiology of Escherichia coli Causing Urinary Tract Infections in United States and in vitro Activity of Tebipenem, Including Against Strain Lineage and Resistant subsets (2018-2020)

BACKGROUND: Tebipenem (TBP) is an oral carbapenem in clinical development for treating complicated urinary tract infections (UTIs), including pyelonephritis. This study investigates the epidemiology of E. coli (EC) causing UTI in U.S. patients and the activity of TBP and comparators against various...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E, Doyle, Timothy B, Critchley, Ian A, Cotroneo, Nicole, Streit, Jennifer M, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644288/
http://dx.doi.org/10.1093/ofid/ofab466.1446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644288/
http://dx.doi.org/10.1093/ofid/ofab466.1446

Ejemplares similares